Bivalent Fv antibody fragments obtained by substituting the constant domains of a fab fragment with heterotetrameric molybdopterin synthase
- PMID: 15328616
- DOI: 10.1016/j.jmb.2004.06.075
Bivalent Fv antibody fragments obtained by substituting the constant domains of a fab fragment with heterotetrameric molybdopterin synthase
Abstract
The antibody Fv fragment is the smallest functional unit of an antibody but for practical use, the VH/VL interface requires stabilization, which is usually accomplished by a peptide linker that joins the two variable domains to form a single chain Fv fragment (scFv). An alternative format to scFv is proposed that (i) allows stabilization of the Fv fragment, and (ii) restores the bivalency of the antibody as a pseudo-F(ab')2 format. This new antibody fragment was constructed by replacing the CHI and CL domains of the Fab fragment with heterotetrameric molybdopterin synthase (MPTS). We found that this format, named MoaFv, improved significantly the cytoplasmic expression of the Fv as a soluble protein in BL21 or Origami Escherichia coli strains. This MoaFv format is expressed as a homogeneous heterotetrameric protein with a Mr value of 110 kDa containing two functional binding sites as revealed by active site titration. In its native condition at 37 degrees C or in the presence of urea, this format was nearly as stable as the corresponding scFv, indicating that non-covalent interactions between the MPTS subunits can replace the covalent peptide linker in scFv. Finally, this MoaFv construct could be a useful format when bivalency is desirable to improve the functional avidity.
Similar articles
-
Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.J Mol Biol. 2001 Sep 7;312(1):221-8. doi: 10.1006/jmbi.2001.4915. J Mol Biol. 2001. PMID: 11545598
-
Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.J Mol Biol. 2005 Apr 8;347(4):773-89. doi: 10.1016/j.jmb.2005.01.053. J Mol Biol. 2005. PMID: 15769469
-
Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.J Immunol. 1985 Oct;135(4):2574-81. J Immunol. 1985. PMID: 3928754
-
[New type recombinant antibody fragment scFv multimer and cancer targeting].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003 Jun;20(2):361-5. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003. PMID: 12856620 Review. Chinese.
-
Pharmacokinetics and biodistribution of genetically-engineered antibodies.Q J Nucl Med. 1998 Dec;42(4):225-41. Q J Nucl Med. 1998. PMID: 9973838 Review.
Cited by
-
Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy.Cancers (Basel). 2022 Aug 30;14(17):4206. doi: 10.3390/cancers14174206. Cancers (Basel). 2022. PMID: 36077739 Free PMC article. Review.
-
Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.Microb Cell Fact. 2009 May 14;8:26. doi: 10.1186/1475-2859-8-26. Microb Cell Fact. 2009. PMID: 19442264 Free PMC article.
-
Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective.Front Immunol. 2022 Aug 23;13:972930. doi: 10.3389/fimmu.2022.972930. eCollection 2022. Front Immunol. 2022. PMID: 36081500 Free PMC article. Review.
-
scFv antibody: principles and clinical application.Clin Dev Immunol. 2012;2012:980250. doi: 10.1155/2012/980250. Epub 2012 Mar 15. Clin Dev Immunol. 2012. PMID: 22474489 Free PMC article. Review.
-
Surface plasmon resonance (SPR) based binding studies of refolded single chain antibody fragments.Biochem Biophys Rep. 2018 Apr 25;14:83-88. doi: 10.1016/j.bbrep.2018.04.005. eCollection 2018 Jul. Biochem Biophys Rep. 2018. PMID: 29872739 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources